Comerica Bank’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,587
| Closed | -$332K | – | 3721 |
|
|
2025
Q2 | $332K | Sell |
2,587
-4,176
| -62% | -$434K | ﹤0.01% | 2086 |
|
|
2025
Q1 | $599K | Sell |
6,763
-6,352
| -48% | -$620K | ﹤0.01% | 1756 |
|
|
2024
Q4 | $1.14M | Buy |
13,115
+10,551
| +412% | +$966K | ﹤0.01% | 1458 |
|
|
2024
Q3 | $237K | Sell |
2,564
-13,100
| -84% | -$1.3M | ﹤0.01% | 2226 |
|
|
2024
Q2 | $1.69M | Buy |
15,664
+4,825
| +45% | +$483K | 0.01% | 1208 |
|
|
2024
Q1 | $1.03M | Buy |
10,839
+10,435
| +2,583% | +$895K | ﹤0.01% | 1521 |
|
|
2023
Q4 | $37.3K | Buy |
404
+1
| +0.2% | +$65 | ﹤0.01% | 2805 |
|
|
2023
Q3 | $20.2K | Buy |
+403
| New | +$21.5K | ﹤0.01% | 3004 |
|
|
2022
Q4 | $3.74M | Buy |
79,000
+6,386
| +9% | +$306K | 0.03% | 724 |
|
|
2022
Q3 | $3.52M | Sell |
72,614
-53,860
| -43% | -$3.46M | 0.03% | 698 |
|
|
2022
Q2 | $7.02M | Buy |
126,474
+17,425
| +16% | +$1.02M | 0.06% | 372 |
|
|
2022
Q1 | $7.37M | Buy |
109,049
+12,927
| +13% | +$928K | 0.05% | 401 |
|
|
2021
Q4 | $7.08M | Sell |
96,122
-1,860
| -2% | -$195K | 0.05% | 406 |
|
|
2021
Q3 | $10M | Sell |
97,982
-4,817
| -5% | -$449K | 0.06% | 348 |
|
|
2021
Q2 | $9.44M | Buy |
102,799
+32,720
| +47% | +$3M | 0.06% | 369 |
|
|
2021
Q1 | $6.8M | Buy |
70,079
+39,686
| +131% | +$3.96M | 0.04% | 556 |
|
|
2020
Q4 | $3.08M | Buy |
30,393
+11,514
| +61% | +$1.21M | 0.02% | 1022 |
|
|
2020
Q3 | $1.98M | Buy |
18,879
+4,457
| +31% | +$343K | 0.01% | 1138 |
|
|
2020
Q2 | $1.13M | Sell |
14,422
-2,609
| -15% | -$176K | 0.01% | 1431 |
|
|
2020
Q1 | $1.2M | Buy |
17,031
+3,128
| +22% | +$201K | 0.01% | 1226 |
|
|
2019
Q4 | $893K | Sell |
13,903
-3,029
| -18% | -$227K | 0.01% | 1625 |
|
|
2019
Q3 | $1.3M | Buy |
16,932
+5,961
| +54% | +$515K | 0.01% | 1365 |
|
|
2019
Q2 | $1.06M | Buy |
10,971
+2,559
| +30% | +$211K | 0.01% | 1500 |
|
|
2019
Q1 | $691K | Sell |
8,412
-4,205
| -33% | -$311K | 0.01% | 1755 |
|
|
2018
Q4 | $878K | Buy |
12,617
+2,180
| +21% | +$132K | 0.01% | 1622 |
|
|
2018
Q3 | $729K | Buy |
+10,437
| New | +$725K | 0.01% | 1736 |
|
Other funds holding BPMC
IA
HNB
Comerica Bank's BPMC Position: Q3 2025 in Review
Comerica Bank sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 2,587 shares — an estimated $332K sold.
Comerica Bank first reported a position in BPMC in Q3 2018 and held it in 26 quarters. The position peaked at $10M in Q3 2021. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Comerica Bank reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Comerica Bank sold 2,587 Blueprint Medicines shares in Q3 2025, an estimated $332K.
- Comerica Bank first reported a position in Blueprint Medicines in Q3 2018 and held it in 26 quarters.
- Comerica Bank's Blueprint Medicines position peaked at $10M in Q3 2021.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Comerica Bank's 13F filing for Q3 2025, filed 14 Nov 2025.